Advertisement
UK markets closed

  • NIKKEI 225

    38,202.37
    -632.73 (-1.63%)
     

  • HANG SENG

    18,313.86
    -165.51 (-0.90%)
     

  • CRUDE OIL

    79.16
    +0.17 (+0.22%)
     

  • GOLD FUTURES

    2,317.20
    -5.10 (-0.22%)
     

  • DOW

    39,056.39
    +172.13 (+0.44%)
     

  • Bitcoin GBP

    49,092.78
    -1,303.22 (-2.59%)
     

  • CMC Crypto 200

    1,302.77
    +8.10 (+0.63%)
     

  • NASDAQ Composite

    16,302.76
    -29.80 (-0.18%)
     

  • UK FTSE All Share

    4,544.24
    +21.25 (+0.47%)
     
Money:

How to make a tax-free income

Tips for making money that won't be taxed

GSK faces bribery investigation in Poland -BBC

Reuters - UK Focus

April 14 (Reuters) - GlaxoSmithKline Plc (Other OTC: GLAXF - news) is facing a criminal investigation in Poland for allegedly bribing doctors to promote its asthma drug Seretide, BBC Panorama reported on Sunday.

The BBC reported that 11 doctors and a GSK regional manager have been charged over alleged corruption between 2010 and 2012.

"The investigation found evidence of inappropriate communication in contravention of GSK policy by a single employee. The employee concerned was reprimanded and disciplined as a result," the drugmaker was quoted as saying.

GSK could not be reached immediately outside regular working hours.

ADVERTISEMENT

According to the BBC, one doctor has admitted guilt and has been fined and given a suspended sentence.

GSK, Britain's biggest drugmaker, was accused by Chinese authorities in July of funnelling up to 3 billion yuan ($483 million) to doctors and officials to encourage them to use its medicines in a case that rocked the pharmaceuticals industry. ($1 = 6.2113 Chinese Yuan) (Reporting by Karen Rebelo in Bangalore; Editing by Leslie Adler)